# Clinical Drug Investigation

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/clinical-drug-investigation/

## Facts

| Field | Value |
| --- | --- |
| APC (USD) | 3,790 |
| Citations | 59,278 |
| h-index | 81 |
| Homepage | https://www.springer.com/journal/40261 |
| Open Access | false |
| ISSN-L | 0114-2402 |
| ISSNs | 0114-2402,1173-2563,1179-1918,2196-4920 |
| OpenAlex ID | https://openalex.org/S138241747 |
| Publisher | Adis, Springer Healthcare |
| Works | 4,134 |

## Journal papers

- [The Safety of Melatonin in Humans](https://scholariq.org/papers/the-safety-of-melatonin-in-humans/)
- [Comparing Pioglitazone to Insulin with Respect to Cancer, Cardiovascular and Bone Fracture Endpoints, Using Propensity Score Weights](https://scholariq.org/papers/comparing-pioglitazone-to-insulin-with-respect-to-cancer-cardiovascular-and-bone/)
- [Comparison of Glyburide with Metformin in Treating Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis](https://scholariq.org/papers/comparison-of-glyburide-with-metformin-in-treating-gestational-diabetes-mellitus/)
- [Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends](https://scholariq.org/papers/nonmetastatic-castration-resistant-prostate-cancer-current-challenges-and-trends/)
- [Cost-effectiveness of Teriflunomide Compared to Interferon Beta-1b for Relapsing Multiple Sclerosis Patients in China](https://scholariq.org/papers/cost-effectiveness-of-teriflunomide-compared-to-interferon-beta-1b-for-relapsing/)
- [Risk of Urinary Tract Infection in Patients with Type 2 Diabetes Mellitus Treated with Dapagliflozin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials](https://scholariq.org/papers/risk-of-urinary-tract-infection-in-patients-with-type-2-diabetes-mellitus/)
- [Disease Burden, Early Discontinuation, and Healthcare Costs in Hepatitis C Patients with and without Chronic Kidney Disease Treated with Interferon-Free Direct-Acting Antiviral Regimens](https://scholariq.org/papers/disease-burden-early-discontinuation-and-healthcare-costs-in-hepatitis-c/)
- [Cost-Effectiveness Analysis of Regorafenib for Gastrointestinal Stromal Tumour (GIST) in Germany](https://scholariq.org/papers/cost-effectiveness-analysis-of-regorafenib-for-gastrointestinal-stromal-tumour/)
- [The Cost Effectiveness of Adjunctive Medical Cannabis Therapy in the Treatment of Moderate Post-Traumatic Stress Disorder](https://scholariq.org/papers/the-cost-effectiveness-of-adjunctive-medical-cannabis-therapy-in-the-treatment/)
- [Randomised Controlled Trial Evidence on Medicinal Cannabis for Treatment of Mental Health and Substance Use Disorders: A Scoping Review](https://scholariq.org/papers/randomised-controlled-trial-evidence-on-medicinal-cannabis-for-treatment-of/)

## Journal top topics

Showing 8 of 25.

- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Antibiotics Pharmacokinetics and Efficacy](https://scholariq.org/topics/antibiotics-pharmacokinetics-and-efficacy/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Inflammatory mediators and NSAID effects](https://scholariq.org/topics/inflammatory-mediators-and-nsaid-effects/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Pain Management and Opioid Use](https://scholariq.org/topics/pain-management-and-opioid-use/)
- [Pharmacogenetics and Drug Metabolism](https://scholariq.org/topics/pharmacogenetics-and-drug-metabolism/)
- [Pneumonia and Respiratory Infections](https://scholariq.org/topics/pneumonia-and-respiratory-infections/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.